Jean Jacques Michels

Summary

Country: France

Publications

  1. ncbi Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma
    Jean Jacques Michels
    Department of Pathology, Centre Francois Baclesse, 14016 Caen Cedex 05, France
    Hum Pathol 38:212-9. 2007
  2. ncbi Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity
    J J Michels
    Department of Pathology, Centre Francois Baclesse, Caen, France
    Breast Cancer Res Treat 62:117-26. 2000
  3. ncbi Flow cytometry in primary breast carcinomas: prognostic impact of multiploidy and hypoploidy
    Jean Jacques Michels
    Department of Pathology, Centre Francois Baclesse, Caen, France
    Cytometry B Clin Cytom 55:37-45. 2003
  4. ncbi Proliferative activity in primary breast carcinomas is a salient prognostic factor
    Jean Jacques Michels
    Department of Pathology, Centre Francois Baclesse, Caen, France
    Cancer 100:455-64. 2004
  5. ncbi Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns
    Jean Jacques Michels
    Department of Pathology, Centre Francois Baclesse, Cannes, France
    Cytometry B Clin Cytom 59:32-9. 2004
  6. ncbi Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma: prognostic significance
    Jean Jacques Michels
    Department of Pathology, Centre Francois Baclesse, Caen, France
    Cancer 97:1376-86. 2003
  7. ncbi [Primary thyroid lymphomas: clinicopathologic study of 30 cases and review of the literature]
    Jean Jacques Michels
    Service d Anatomie Pathologique, Centre Francois Baclesse, 14076 Caen Cedex, France
    Ann Pathol 22:10-7. 2002
  8. ncbi High grade primary breast lymphoma: is it a different clinical entity?
    Christophe Fruchart
    Department of Clinical Oncology, Centre Francois Baclesse, Caen, France
    Breast Cancer Res Treat 93:191-8. 2005
  9. doi Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma
    Stephane Bardet
    Department of Nuclear Medicine and Thyroid Unit, Centre Francois Baclesse, 3 Avenue Général Harris, BP 5026, F 14076 Caen Cedex 05, France
    Eur J Endocrinol 158:551-60. 2008
  10. ncbi Unusual short-term complete response to two regimens of cytotoxic chemotherapy in a patient with poorly differentiated thyroid carcinoma
    Geneviève Crouzeix
    Department of Nuclear Medicine and Thyroid Unit, Centre Francois Baclesse, F 14076 Caen Cedex 05, France
    J Clin Endocrinol Metab 97:3046-50. 2012

Collaborators

Detail Information

Publications19

  1. ncbi Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma
    Jean Jacques Michels
    Department of Pathology, Centre Francois Baclesse, 14016 Caen Cedex 05, France
    Hum Pathol 38:212-9. 2007
    ..In this large cohort of patients, TCV represents 8.3% of PTC, and it is a more aggressive form of PTC than CF because of the higher stage and increased grade...
  2. ncbi Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity
    J J Michels
    Department of Pathology, Centre Francois Baclesse, Caen, France
    Breast Cancer Res Treat 62:117-26. 2000
    ..When estimated from fresh or frozen material following AC's guidelines. SPF along with mitotic activity should become a prognostic factor used in the daily practice by oncologists in the management of breast carcinomas...
  3. ncbi Flow cytometry in primary breast carcinomas: prognostic impact of multiploidy and hypoploidy
    Jean Jacques Michels
    Department of Pathology, Centre Francois Baclesse, Caen, France
    Cytometry B Clin Cytom 55:37-45. 2003
    ..The aims of the present work were to study the prognostic impact of multiploidy and/or hypoploidy in breast cancers and their relation to other classic clinicopathologic prognostic factors (T, grade, receptors, and lymph node status)...
  4. ncbi Proliferative activity in primary breast carcinomas is a salient prognostic factor
    Jean Jacques Michels
    Department of Pathology, Centre Francois Baclesse, Caen, France
    Cancer 100:455-64. 2004
    ....
  5. ncbi Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns
    Jean Jacques Michels
    Department of Pathology, Centre Francois Baclesse, Cannes, France
    Cytometry B Clin Cytom 59:32-9. 2004
    ..The definition of euploidy varied according to the author; some of them even included aneuploid peaks with few events. A comparison was also drawn to the average SPF and the diploid peak SPF observed in aneuploid histograms...
  6. ncbi Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma: prognostic significance
    Jean Jacques Michels
    Department of Pathology, Centre Francois Baclesse, Caen, France
    Cancer 97:1376-86. 2003
    ..Between January 11, 1991 and January 8, 1992, 104 patients with previously untreated, invasive, primitive breast carcinoma were admitted to the authors' hospital...
  7. ncbi [Primary thyroid lymphomas: clinicopathologic study of 30 cases and review of the literature]
    Jean Jacques Michels
    Service d Anatomie Pathologique, Centre Francois Baclesse, 14076 Caen Cedex, France
    Ann Pathol 22:10-7. 2002
    ..20 patients died (62%), 12 from the lymphoma and 8 from intercurrent causes. The overall survival at 5 years was 36% (9 5% CI 16 54%). A comparison of our results with those of the literature was performed...
  8. ncbi High grade primary breast lymphoma: is it a different clinical entity?
    Christophe Fruchart
    Department of Clinical Oncology, Centre Francois Baclesse, Caen, France
    Breast Cancer Res Treat 93:191-8. 2005
    ..The treatment should be based on the same modalities, but including a CNS prophylaxis even if poor prognosis factors are lacking. A radical mastectomy increases the risk of treatment failure and has to be avoided...
  9. doi Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma
    Stephane Bardet
    Department of Nuclear Medicine and Thyroid Unit, Centre Francois Baclesse, 3 Avenue Général Harris, BP 5026, F 14076 Caen Cedex 05, France
    Eur J Endocrinol 158:551-60. 2008
    ..A retrospective study was conducted to assess the influence of various LND procedures and to search for LNR risk factors...
  10. ncbi Unusual short-term complete response to two regimens of cytotoxic chemotherapy in a patient with poorly differentiated thyroid carcinoma
    Geneviève Crouzeix
    Department of Nuclear Medicine and Thyroid Unit, Centre Francois Baclesse, F 14076 Caen Cedex 05, France
    J Clin Endocrinol Metab 97:3046-50. 2012
    ..Molecular targeted therapy with multikinase inhibitors has recently shown promising results, and cytotoxic chemotherapy is generally considered of low efficacy...
  11. doi [What diagnosis can be made by the pathologist in a case of sclerosing thyroiditis?]
    Jean Jacques Michels
    Service d Anatomie Pathologique, Centre Francois Baclesse, Avenue du General Harris, 14076 Caen Cedex 5, France
    Ann Pathol 28:263-7. 2008
    ..In these cases, we think the diagnosis of sclerosing thyroiditis NOS would be more appropriate, the histology not being sufficiently characteristic to make a more specific diagnosis...
  12. doi [Treatment of primary thyroid lymphomas]
    Xu Shan Sun
    CHRU de Besancon, Departement de Radiotherapie, 3, Boulevard Fleming, 25030 Besancon, France, Centre Hospitalier Belfort Montbeliard, Departement de Radiotherapie, Boulevard du Marechal Juin, 25209 Montbeliard Cedex, France
    Bull Cancer 100:1031-42. 2013
    ..Localized MALT lymphomas can be treated with radiation alone. The treatment of other LPT is presented. ..
  13. ncbi Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissues: clinicopathologic and molecular analysis of 44 patients from the French sarcoma group
    Jean Michel Coindre
    Department of Pathology, Institut Bergonie, Bordeaux, France
    Cancer 107:1055-64. 2006
    ..The diagnosis of CCS usually is easy but may be challenging in unusual sites, and the detection of EWS-ATF1 fusion transcripts is helpful to rule out a metastatic melanoma...
  14. ncbi Human herpesvirus 8 immunostaining: a sensitive and specific method for diagnosing Kaposi sarcoma in paraffin-embedded sections
    Yves Marie Robin
    Department of Pathology, Oscar Lambret Cancer Center, Lille, France
    Am J Clin Pathol 121:330-4. 2004
    ..The LNA-1 anti-HHV-8 antibody is a reliable marker of all variants of KS. Because KS mimickers are consistently negative for this marker, its use for diagnostic purposes is recommended...
  15. ncbi Malignant pilomatricoma: two new observations and review of the relevant literature
    Mohamed Allaoui
    Department of Biopathology, François Baclesse Cancer Center, Caen, France
    Turk Patoloji Derg 30:66-8. 2014
    ..Surgical wide resection is the recommended treatment. It reduces the risk of focal recurrence by 50%. Here we report two new cases including one that occurred on a lesion initially diagnosed as benign pilomatricoma. ..
  16. ncbi Risk of second primary cancer following differentiated thyroid cancer
    Emmanuelle Berthe
    Service de Medecine Nucleaire, CLCC François Baclesse, Avenue Général Harris, 14076, Caen Cedex 05, France
    Eur J Nucl Med Mol Imaging 31:685-91. 2004
    ..Only age and medical history of primary cancer before thyroid carcinoma are risk factors for second cancer. Common environmental or genetic factors as well as long-term carcinogenic effects of primary cancer therapy should be considered...
  17. ncbi Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group
    Sandra Gebhard
    University Institute of Pathology, Lausanne, Switzerland
    Am J Surg Pathol 26:601-16. 2002
    ..It shows a wide range of morphologic appearances, but tumor grade and histology have no effect on patient outcome...
  18. ncbi Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis
    Louis Guillou
    Institut Universitaire de Pathologie, Rue du Bugnon 25, 1011 Lausanne, Suisse
    J Clin Oncol 22:4040-50. 2004
    ..To assess the prognostic value of SYT-SSX fusion type, in comparison with other factors, in a population of 165 patients with synovial sarcoma (SS)...
  19. ncbi Vascular proliferations of the skin after radiation therapy for breast cancer: clinicopathologic analysis of a series in favor of a benign process: a study from the French Sarcoma Group
    Carole Gengler
    Department of Pathology, University Institute of Pathology, Lausanne, Switzerland
    Cancer 109:1584-98. 2007
    ....